Common Contracts

2 similar Transition and Consulting Agreement contracts by IGM Biosciences, Inc.

TRANSITION AND CONSULTING AGREEMENT
Transition and Consulting Agreement • November 8th, 2024 • IGM Biosciences, Inc. • Pharmaceutical preparations • California

This Transition and Consulting Agreement (“Agreement”) is made effective as of October 1, 2024 (the “Effective Date”), by and between IGM Biosciences, Inc., a Delaware corporation having an address at 325 East Middlefield Road, Mountain View, CA 94043 (“IGM”), and Bruce Keyt, an individual having an address at 1180 Lakeview Drive, Hillsborough, CA 94010 (“Consultant” and together with “IGM” the “Parties”).

TRANSITION AND CONSULTING AGREEMENT
Transition and Consulting Agreement • November 8th, 2024 • IGM Biosciences, Inc. • Pharmaceutical preparations • California

This Transition and Consulting Agreement (“Agreement”) is made effective as of September 30, 2024 (the “Effective Date”), by and between IGM Biosciences, Inc., a Delaware corporation having an address at 325 East Middlefield Road, Mountain View, CA 94043 (“IGM”), and Fred Schwarzer, an individual having an address at 553 Mimosa Court, Los Altos, CA 94024 (“Consultant” and together with “IGM” the “Parties”).